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Background: Physical and Mental Component Summary (PCS, MCS, respectively) scales of SF- 36 health-related-quality-
of-life have been associated with all-cause and cardiovascular disease (CVD) mortality. Their relationships with CVD
incidence are unclear. This study purpose was to test whether PCS and/or MCS were associated with CVD incidence
and death.
Methods: Postmenopausal women (aged 50–79 years) in control groups of the Women’s Health Initiative clinical trials
(n = 20,308) completed the SF-36 and standardized questionnaires at trial entry. Health outcomes, assessed semi-annually,
were verified with medical records. Cox regressions assessed time to selected outcomes during the trial phase
(1993–2005).
Results: A total of 1075 incident CVD events, 204 CVD-specific deaths, and 1043 total deaths occurred during the trial
phase. Women with low versus high baseline PCS scores had less favorable health profiles at baseline. In multivariable
models adjusting for baseline confounders, participants in the lowest PCS quintile (reference = highest quintile)
exhibited 1.8 (95%CI: 1.4, 2.3), 4.7 (95%CI: 2.3, 9.4), and 2.1 (95%CI: 1.7, 2.7) times greater risk of CVD incidence,
CVD-specific death, and total mortality, respectively, by trial end; whereas, MCS was not significantly associated
with CVD incidence or death.
Conclusion: Physical health, assessed by self-report of physical functioning, is a strong predictor of CVD
incidence and death in postmenopausal women; similar self-assessment of mental health is not. PCS should be
evaluated as a screening tool to identify older women at high risk for CVD development and death.
Keywords: Physical component summary, Mental component summary, Cardiovascular disease, All-cause deathBackground
Health-Related-Quality-of-Life (HRQOL) is strongly as-
sociated with cardiovascular disease (CVD) specific and
all-cause mortality risk in older adults but its associ-
ation with CVD incidence is unknown [1-7]. It is plaus-
ible that HRQOL will be associated with incident CVD
since it is correlated with a set of risk factors (e.g. obesity,
physical inactivity, and low-fiber diet) that are common
to both CVD and mortality [8,9]. There is evidence
that HRQOL is associated with specific types of CVD,* Correspondence: nsaquib@stanford.edu
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Establishing relationships between HRQOL with incident
CVD, the leading cause of death in the U.S., has practical
implications as it could be used to screen individuals who
are at risk of CVD development [12].
Of the HRQOL instruments, Short-Form (SF)-36-survey
is widely used in research and is represented by its two
summary scores: Physical Component Summary (PCS)
and Mental Component Summary (MCS) [13]. PCS gener-
ally signifies the physical domain of health and exhibits a
stronger association with mortality than MCS (i.e. mental
domain of health) in the adjusted models; both of their
effects on mortality are independent of their correlationLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[1,2,6,14].
The Women’s Health Initiative (WHI), a large US-based
study of postmenopausal women had baseline assessment
of SF-36, adjudicated CVD outcomes, and long follow-up.
We aimed to assess the relationship of SF-36 summary
scores (i.e. PCS and MCS) with CVD outcomes and all-
cause mortality. We hypothesized that women with low
PCS and/or MCS scores would be at increased risk of
developing CVD as well as at increased risk of dying
from CVD specifically or from all causes.
Methods
Overview of the WHI
Details of eligibility criteria, data collection, and ascertain-
ment of health outcomes in the WHI Study have been
reported previously [15]. Briefly, the Clinical Trials
(CT) included 68,132 post-menopausal women (ages
50–79 years) who were recruited at 40 clinical centers
throughout the U.S. and randomly assigned to one or
more clinical trials: the Dietary Modification (DM) trial,
the Hormone Therapy (HT) trials, and/or the Calcium
and Vitamin D (CaD) trial. Participants were ineligible
if they had medical conditions with a predicted survival
of 3 years or less, or had any condition that made them
unable to adhere to study interventions (i.e. alcohol or
drug-dependency, or dementia), or if they were enrolled
in another trial. Women who were ineligible or unwilling to
join either the HT or DM trials were invited to join an Ob-
servational Study (OS), which enrolled 93,676. Study proce-
dures and protocols were approved by the Institutional
Review Boards at the National Institute of Health and at
all forty participating institutions; participants provided
written informed consent (Additional file 1: Table S1).
Rationale for sample selection
These analyses were limited to the 26,515 control partici-
pants (all 3 trials) to ensure that the various trial interven-
tions (i.e. hormone therapy, dietary modification, calcium
and vitamin D) did not confound the study results. Of
these, 5,965 were excluded from the analyses due to
missing data at baseline: 242 participants did not fill out
data collection forms, 1,271 had missing SF-36 values,
and 4,694 were missing key covariate values in the statis-
tical model. Complete data on exposure, outcomes, and
specified covariates were available for the remaining
20,308 women (Figure 1).
SF-36 quality-of-life assessments
At trial entry, participants completed the SF-36 HRQOL
survey. The SF-36 assesses four physical subscales: (1) gen-
eral health perceptions, (2) physical functioning (i.e. the
ability to perform vigorous or moderate intensity activ-
ities that one might do in a typical day), (3) bodily pain,and (4) role limitations (i.e. problem with work and
other regular daily activities due to physical health; and
four mental subscales: (1) mental health, (2) vitality,
(3) role limitations due to emotional problems, and (4)
social functioning) [16,17]. For each subscale, overall
scores were obtained by summing responses to the indi-
vidual questions linked to that particular subscale. Each
subscale score ranged from 0 to 100, with 0 denoting ‘bad
health’ and 100 denoting ‘good health’. These scales have
been shown to be reliable and have adequate construct
validity in populations with a variety of disease-specific
medical diagnoses [18]. All eight subscales are included
in the computation of the physical and the mental com-
ponent summary scores (PCS and MCS respectively),
but the weight of each individual subscale varies ac-
cording to algorithms specified by the SF-36 survey
developers [13,16].
Other assessments
Standardized questionnaires administered at trial entry
ascertained demographic characteristics including age, eth-
nicity (White, African-American, Asian or Pacific Islander,
Hispanic/Latino, American Indian or Alaskan Native, and
Other), education level (less than high-school, high-school,
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(never married, married, and divorced/widowed), employed
(yes, no), drinking status (none, past, current), and smoking
status (current, past, and non-smokers). Pack-years of
cigarette smoking were computed by multiplying the
midpoint of the smoking frequency interval with the
midpoint of the duration interval and dividing the product
by 20 [19]. Fruits and vegetables consumption was assessed
with a standardized Food Frequency Questionnaire (FFQ)
and categorized as <3, 3–5, and 5+ servings/day [20].
Weight and height were measured by clinic staff at
baseline with the participants wearing light clothing and
no shoes. Body mass index (BMI) was calculated as weight
in kilograms divided by height in meters squared and
was categorized as normal (< 25 kg/m2), overweight
(25–29.9 kg/m2), or obese (≥30 kg/m2). Systolic and dia-
stolic blood pressures were measured according to a
standardized protocol and were expressed in millimeter
of mercury.
Physical activity (PA) at baseline was assessed using a
validated 9-item measure of physical activity from the
‘Personal Habits Questionnaire’ and was expressed in meta-
bolic equivalent of task (MET)-minutes per week [21].
Participants were categorized as ‘sedentary’ (<30 minutes
of physical activity weekly or <90 MET/wk), ‘insufficient
PA’ (90 – 449 MET/wk), ‘meets the recommended level’
(450 – 600 MET/wk), or ‘exceed the recommended
level’ (> 600 MET/wk).
Health related information came from the ‘Medical
History Questionnaire’ administered at baseline. Partici-
pants were asked whether they had ever received a physi-
cian’s diagnosis of: diabetes, hypertension, cardiovascular
disease, asthma, emphysema, cancer except non-melanoma
skin cancer, Alzheimer’s disease, multiple sclerosis, and
Parkinson’s disease; or whether they were on cholesterol-
lowering medication.
Outcomes assessment
Three WHI primary outcomes were selected: (1) time to
incident CVD (fatal and non-fatal), (2) time to death due
to CVD, and (3) time to death from any cause. A CVD
event was defined as having been diagnosed with any of
the following conditions during follow-up: coronary heart
disease, stroke, congestive heart failure, angina, peripheral
vascular disease, carotid artery disease, and coronary re-
vascularization. The information on the outcomes was
probed semi-annually by study personnel; any report of
outcome was documented and corroborated with medical
records. The underlying cause of death was classified on
the basis of the death certificate, medical records, and
other records such as autopsy reports.
The analysis focused on the WHI trial phase (1993–
2005). For incident CVD, follow-up was censored at the
last follow up visit, end of trial, or date of death due toany cause, whichever occurred first. For CVD-specific
death, follow-up was censored at the last follow up visit,
end of trial, or date of death due to any cause other than
CVD, whichever occurred first. For all-cause death,
follow-up was censored at last follow-up visit or end of
trial, whichever occurred first.
Statistical analyses
Exposure and covariates were measured at baseline and
the outcomes were measured at follow-up. A complete
case analysis was employed. A comparison between those
who were eligible and included in the analysis (N =
20,308) and those who were eligible but excluded in the
analysis due to missing exposure or scientific model
variables (N = 5,965) revealed several significant differ-
ences, when these two distributions were compared by
Chi-square tests of association. Differences were not
more than 2-3% for a given variable between the in-
cluded and excluded participants. For example, 10.33%
of those who were excluded died during follow up,
compared to 9.06% of those who were included, with
p-value 0.007.
For the ease of interpretation, PCS and MCS scores
were categorized as quintiles. Correlation between PCS
and MCS quintiles was evaluated with Spearman correl-
ation statistics. Cumulative survival of the outcome events
(CVD incidence, CVD death, and all-cause death) in each
of the PCS and MCS quintiles were graphed with Kaplan
Meier plots and were compared with log-rank test. Cox
proportional hazard regressions were used to determine
the unadjusted and the adjusted associations of PCS and
MCS quintiles with each outcome. Hazard ratios (HR)
and associated 95% confidence intervals (CI) were the
measures of associations.
Interaction term between PCS and MCS for each out-
come was tested prior to model building. A pre-specified
set of variables, based on literature review, was selected
for model adjustment [1,8,10,11,22]. Variables included
participants’ demographic (age at screening, ethnicity,
education, marital status), lifestyle (BMI, physical activity,
fruit and vegetable consumption, smoking and drinking
habits at study entry), and health characteristics [diabetes,
hypertension, COPD (asthma or emphysema), cancer
(except non-melanoma skin cancer), arthritis, medication
use for high cholesterol, and systolic and diastolic blood
pressure at baseline].
For each outcome, analyses were adjusted for con-
founding variables. Models examining the association of
PCS and MCS on outcomes were sequentially adjusted for
age at screening, then demographic, lifestyle and health
characteristics, and finally for MCS (if PCS was the expos-
ure) or PCS (if MCS was the exposure). A sensitivity ana-
lysis, where outcomes that occurred in the first year of
follow-up were excluded, was also conducted. In addition,
Table 1 Association of physical component summary (PCS) quintile with demographics, life-style and health-related
factors (n =20,308)
Physical component summary quintile
Q1 0–40.1
(n = 4062)
Q2 40.2 - 48.3
(n = 4061)
Q3 48.4 - 52.6
(n = 4058)
Q4 52.7 - 55.9
(n = 4066)
Q5 56–75
(n = 4061)
Baseline variable Mean (sd)
or percent
Mean (sd)
or percent
Mean (sd)
or percent
Mean (sd)
or percent
Mean (sd)
or percent
p-value
Agea 64.4 (7.0) 63.7 (7.0) 62.9 (6.8) 62.3(6.8) 60.9(6.5) <0.0001
Age (category)
<0.0001
50–59 26.4 29.2 32.6 36.1 44.2
60–69 47.9 48.3 48.7 47.7 44.2
70-80 25.7 22.5 18.7 16.2 11.6
Ethnicity
<0.0001
White 79.3 81.3 82.7 83.9 84.9
African American 13.7 11.1 9.6 8.3 6.7
Hispanic/Latino 3.5 3.2 3.2 3.1 3.4
Asian/PI 1.4 2.6 2.7 3.0 3.2
AI/AN 0.5 0.4 0.3 0.4 0.3
Other 1.3 1.3 1.3 1.1 1.3
Marital Status
<0.0001
Never married 4.1 3.9 4.2 4.0 4.0
Divorced/widowed 37.8 34.2 30.6 29.7 31.8
Currently married 58.1 61.8 65.2 66.3 64.2
Education
<0.0001
< high-school 7.8 5.7 4.1 3.5 2.9
High-school 20.6 20.4 19.3 16.9 15.8
Some-college 43.8 40.0 39.7 38.0 35.8
College-graduate 27.7 33.9 36.8 41.6 45.4
BMI( kg/m2)a 31.8(7.0) 29.7(5.9) 28.6(5.4) 27.6(5.2) 26.6(4.5) <0.0001
BMI (category)
<0.0001
<25 16.4 22.7 27.0 34.4 40.2
25–29.9 27.8 34.2 38.4 38.5 39.5
≥ 30 55.8 43.1 34.6 27.1 20.3
Physical activity (MET/wk)
<0.0001
< 90 36.4 26.7 22.7 17.0 16.2
90–449 31.1 31.0 28.6 27.4 23.6
450–600 17.7 21.5 22.9 23.5 21.9
> 600 14.8 20.8 25.8 32.1 38.2
FV
0.009
<3 servings/d 43.3 41.3 40.0 39.9 41.5
3–5 servings/d 34.5 35.8 37.3 36.2 35.8
5+ servings/d 22.2 22.9 22.7 23.8 22.6
Pack-yearsa 12.1 (20.6) 10.3(18.4) 9.7(17.7) 8.5(15.7) 8.8(16.0) <0.0001
Smoking status
0.10
Never Smoked 51.6 53.5 54.4 55.1 52.9
Past Smoker 40.3 38.7 38.2 37.9 39.5
Current Smoker 8.2 7.9 7.5 7.0 7.6
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Table 1 Association of physical component summary (PCS) quintile with demographics, life-style and health-related
factors (n =20,308) (Continued)
Alcohol intake
<0.0001
Non drinker 12.1 11.9 11.7 9.0 8.1
Past drinker 27.7 21.0 16.6 15.0 13.8
Current drinker 60.2 67.1 71.7 76.0 78.1
Diabetes = Yes 12.6 8.2 6.3 3.7 2.2 <0.0001
COPD = yes 16.3 11.8 8.7 7.1 5.4 <0.0001
Arthritis = yes 73.8 57.9 44.2 32.6 23.2 <0.0001
CVD = Yes 27.1 19.2 15.0 11.2 9.1 <0.0001
Ever Cancer = yes 6.2 4.7 3.9 3.6 3.6 <0.0001
HTN = yes 50.8 40.6 35.6 28.8 20.7 <0.0001
Systolic BP a 131.3(17.5) 129.6(17.5) 128.8(17.7) 126.7(17.0) 123.9(16.6) <0.0001
Diastolic BP a 76.3(9.4) 75.9(9.1) 76.2(9.2) 75.8(8.9) 75.1(8.7) <0.0001
MCS a 54.1(9.3) 53.6(8.1) 53.9(7.2) 54.2(6.5) 50.5(9.5) <0.0001
a Data are presented as mean (SD); all other data are presented as percent per quintile.
PI = Pacific Islander, AI = American Indian, AN = Alaskan Native, BMI = body mass index, BP = blood pressure, COPD = Chronic obstructive pulmonary disease
(asthma or emphysema), CVD = cardiovascular diseases, FV = fruits and vegetables, HTN = hypertension, MCS =Mental component summary, MET =Metabolic
equivalent of task, Q = quintile, SD = standard deviation.
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of SF-36 with the outcomes. The aforementioned covar-
iates were used for the adjustment.
Participants with CVD at baseline were excluded from
the incident CVD and CVD-specific death models. To
examine the effect of CVD at baseline, the all-cause death
model was run with and without participants who had
CVD at baseline. The all-cause death model presented in
the tables and graphs included those with CVD at base-
line. All tests were two-sided and analyses were conducted
in SAS version 9.2 (Cary, NC).
Results
Sample characteristics
Women in the analytic sample (n=20,308) had a mean
age of 62.8 years [standard deviation (SD): 6.9] and a mean
BMI of 28.9 kg/m2 (SD: 5.9); 37.2% were college graduates,
63.1% were married, and 38.6% were employed. Partici-
pants self-identified their race/ethnicity as: White = 82.3%,
African-American = 9.9%, Hispanic/Latino = 3.5%, Asian/
Pacific Islander = 2.3%, and American Indian/Alaskan
Native = 0.4%.
Sample characteristics by PCS and MCS quintiles (Q)
Participants’ PCS and MCS score were strongly associated
with demographic, life-style, and disease-related variables
but the distributions across the quintiles differed (Tables 1
& 2). For example, whereas the mean age decreased incre-
mentally across the quintiles of PCS, it increased across
the quintiles of MCS. In the lowest PCS quintile (refer-
ence highest quintile), the proportion of participants withobesity was greater by 3 times, with diabetes by roughly 6
times, and with HTN, CVD, COPD, or arthritis by nearly
3 times. On the other hand, the proportions of partici-
pants with these conditions were similar between the
lowest and the highest MCS quintiles (Tables 1 & 2). PCS
and MCS quintiles were significantly correlated with one
another (spearman correlation: -0.12, p-value <0.0001).
Unadjusted associations of PCS and MCS quintiles with
CVD incidence, CVD death, and all-cause death
Kaplan-Meier plots of time to CVD incidence, CVD-
specific death, or all-cause death were significant for
both PCS and MCS. Unadjusted Cox model showed that
risk estimates (for all 3 outcomes) increased in the compari-
son PCS quintiles and they decreased in the comparison
MCS quintiles (compared to respective reference quintile,
Figure 2). Interaction term between PCS and MCS was not
significant for any of the outcomes (p values >0.25).
Adjusted associations of PCS and MCS quintiles with CVD
incidence, CVD death, and all-cause death
Age-adjustment substantially reduced the risk estimates
of PCS quintiles; however, the HR remained significant
for each comparison quintile (Q1-Q4) for CVD incidence
and CVD death, and for the lowest 3 quintiles (Q1-Q3)
for all cause death. Adjustment for the remaining covari-
ates, except MCS, attenuated the risks further, and for
CVD incidence the HR of Q4 and Q3 quintile lost statis-
tical significance (Data not shown). Additional adjustment
for MCS scores hardly made any difference to the risk
estimates (Table 3). For all-cause death, the estimates in
Table 2 Association of mental component summary (MCS) quintile with demographics, life-style, and health-related
factors (n =20,308)
Mental component summary quintile
Q1 0 – 48.0
(n = 4061)
Q2 48.1 – 54.0
(n = 4063)
Q3 54.1 – 57.0
(n = 4061)
Q4 57.1 – 59.3
(n = 4065)
Q5 59.4 - 75
(n = 4058)
Baseline variable Mean (sd)
or percent
Mean (sd)
or percent
Mean (sd)
or percent
Mean (sd)
or percent
Mean (sd)
or percent
p-value
Age a 61.8(7.2) 62.2(6.8) 62.5(6.8) 63.0(6.7) 64.8(6.8) <0.0001
Age (category)
<0.0001
50–59 41.2 37.0 35.7 31.5 22.9
60–69 41.8 46.8 47.1 50.1 50.9
70-80 16.9 16.1 17.1 18.3 26.2
Ethnicity
<0.0001
White 78.6 81.2 84.4 84.6 83.3
African American 12.7 10.4 8.4 8.4 9.5
Hispanic/Latino 4.1 3.9 3.0 2.6 2.8
Asian/PI 2.3 2.5 2.7 2.8 2.6
AI/AN 0.6 0.3 0.3 0.4 0.3
Other 1.5 1.5 0.9 1.0 1.3
Marital Status
Never married 4.3 4.2 4.2 3.5 4.0
<0.0001Divorced/Widowed 38.7 33.3 29.3 29.7 33.3
Currently married 57.0 62.5 66.7 66.8 62.7
Education
Less than high-school 6.7 5.2 4.4 3.0 4.7
<0.0001
High-school 20.5 19.1 18.1 17.3 18.0
Some-college 39.7 39.2 38.2 38.5 41.6
College-graduate 33.1 36.5 39.2 41.0 35.6
BMI( kg/m2) a 29.3(6.2) 28.8(5.9) 28.3(5.7) 28.2(5.5) 29.7(6.3) <0.0001
BMI (category)
<25 25.0 28.9 31.2 31.3 24.2
<0.000125–29.9 35.6 35.7 36.7 36.3 34.1
≥ 30 39.4 35.4 32.1 32.4 41.7
Physical activity (MET/wk)
< 90 30.2 25.1 20.4 19.3 24.2
<0.0001
90–449 29.7 29.7 27.9 27.4 26.9
450–600 18.8 21.0 23.1 22.3 22.3
> 600 21.3 24.2 28.6 31.0 26.6
FV
0.009
<3 servings/d 48.5 43.6 40.0 36.3 37.7
3–5 servings/d 31.6 35.8 36.5 38.8 37.0
5+ servings/d 19.9 20.6 23.5 24.9 25.3
Pack-years a 11.1 (19.2) 10.0(17.6) 9.4(17.4) 9.2(16.8) 9.6(17.8) <0.0001
Smoking status
Never Smoked 51.4 52.1 53.7 53.8 56.4
<0.0001Past Smoker 38.0 39.0 39.6 40.1 37.9
Current Smoker 10.6 8.9 6.7 6.2 5.7
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Table 2 Association of mental component summary (MCS) quintile with demographics, life-style, and health-related
factors (n =20,308) (Continued)
Alcohol intake
Non drinker 9.8 9.5 10.1 10.9 12.5
<0.0001Past drinker 22.0 20.1 17.4 15.6 19.0
Current drinker 68.2 70.4 72.5 73.6 68.5
Diabetes = Yes 8.0 6.9 6.1 4.5 7.0 <0.0001
COPD = yes 12.3 10.2 8.2 8.4 10.2 <0.0001
Arthritis = yes 50.6 44.2 41.1 41.6 54.3 <0.0001
CVD = Yes 18.7 16.8 15.5 13.8 16.8 <0.0001
Ever Cancer = yes 4.7 5.4 4.1 4.0 3.8 <0.0001
HTN = yes 37.5 36.0 33.4 32.6 36.9 <0.0001
Systolic BP a 127.6(17.5) 127.7(17.6) 127.5(17.4) 127.9(17.2) 129.6(17.3) <0.0001
Diastolic BP a 76.1(9.1) 75.8(9.3) 75.8(9.2) 75.8(8.9) 75.8(9.1) 0.69
MCS a 48.5(10.8) 48.8(8.9) 49.4(8.4) 49.5(8.3) 43.7(10.4) <0.0001
a Data are presented as mean (SD); all other data are presented as percent per quintile.
PI = Pacific Islander, AI = American Indian, AN = Alaskan Native, BMI = body mass index, BP = blood pressure, COPD = Chronic obstructive pulmonary disease
(asthma or emphysema), CVD = cardiovascular diseases, FV = fruits and vegetables, HTN = hypertension, MET =Metabolic equivalent of task, PCS = Physical
component summary, Q = quintile, SD = standard deviation.
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with CVD at baseline were excluded (Data not shown).
The risk estimates of the comparison MCS score quin-
tiles changed in successive adjustment steps: first with
age adjustment, then with all other selected covariates
(except PCS), and finally with PCS scores. The HRs of final
model for each outcome had a very modest U-shaped
pattern of associations, although the comparison quin-
tiles were not significant, except the 3rd quintile in rela-
tion to CVD incidence (Table 3).Sensitivity analysis (PH quintiles & the selected outcomes)
When the events that occurred in the first year of the trial
were excluded, participants’ PCS scores remained signifi-
cantly associated with CVD incidence, CVD-specific death,
and all-cause death. A comparison of HRs between the
adjusted models, with or without the exclusions of events,
indicated little change in the estimate and no change in
the significance (data not shown).Adjusted associations of SF-36 subscales with CVD
incidence, CVD death, and all-cause death
Fully adjusted models showed that among the eight sub-
scales of SF-36, physical functioning was significantly
associated with all outcomes; each 10-point increase
in the physical functioning score was associated with 7%
reduction in CVD incidence, 13% reduction in CVD
specific death, and 8% reduction in all-cause death.
Additionally, general health perception was significantly
associated with all-cause death. The other subscaleswere not significantly associated with any outcome
(Additional file 2: Table S2).Discussion
This report shows that physical functional health, as
derived from the SF-36 HRQOL, is a significant inde-
pendent predictor of CVD incidence in older women.
Specifically, women who were in the bottom 2 quintiles
(Q1, Q2) were at 80% and 60% higher risk of developing
CVD, respectively, than those in the top quintile (Q5).
The significant risk of CVD associated with low PCS
scores exceeds the risk of other lifestyle related CVD risk
factors such as obesity, physical inactivity, smoking, and
poor dietary habit associated with low PCS. Further this
study validates the EPIC-Norfolk and NHS findings by
showing that a low PCS score is a strong predictor of
death, either from CVD or from all-causes [1,14].
A couple of hypothesis such as ‘disease severity’ and
‘subclinical disease’ have been proposed to explain the
associations of PCS with mortality (i.e. individuals with a
low PCS score are either overtly diseased or have disease
that are not clinically manifested yet). These hypotheses
cannot be rejected with the present analysis; however,
they are unlikely to explain fully the findings of this
study. The strong association of low PCS scores on CVD
incidence and death, despite exclusion of events in the
first year (sensitivity analysis) and inclusion of indicators
of poor health in the model (e.g. diagnosis with diabetes,
hypertension, COPD, arthritis, or cancer, use of medica-
tion for hypertension or high cholesterol), argues against
Figure 2 Unadjusted plots for study outcomes. (a-f) Kaplan Meier survival plots of cardiovascular (CVD) incidence, CVD-specific and all-cause
death (n = 20,308). The hazard ratios and the associated 95% CI are the unadjusted estimates for Physical Component Summary (PCS) and Mental
Component Summary (MCS) quintiles (Q).
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up data (mean 9.2 years) and inclusion of CVD related
marker (e.g. blood pressure) in the model argues against
the ‘subclinical disease’ hypothesis.
A reflection on the questions that constitute the PCS
scale may provide insight on why PCS scores strongly
predict CVD health and death. SF-36 items that com-
poses the PCS scale ask participants to assess their gen-
eral health while others inquire about bodily pain, the
level of ease with which they can perform certain types
of physical activities of daily living, and the activities thatthey recently had to cut back due to reduced physical
function. The questions may capture several psychological
constructs indirectly in addition to measuring perceived
physical health directly. For example, high PCS scores
may reflect higher levels of optimism while low scores
may be indicative of higher levels of hopelessness and
negative attitudes. In fact, these psychological constructs
have been associated with CVD incidence and CVD spe-
cific mortality [23-25].
In this study, the MCS score, which was marginally as-
sociated with study outcomes when considered alone,
Table 3 Adjusted association of cardiovascular (CVD) incidence, CVD-specific, and all-cause death (1993–2005; n = 20,308)
SF 36 Physical summary component quintile
Q1: 0–40.1
(n = 4062)
Q2: 40.2 - 48.3
(n = 4061)
Q3: 48.4 - 52.6
(n = 4058)
Q4: 52.7 - 55.9
(n = 4066)
Q5: 56–75
(n = 4061)
Events/N HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) Ref p-value
CVD incidence a 1075/16994 1.80 (1.43, 2.27) 1.57(1.25, 1.96) 1.09(0.86, 1.37) 1.25(0.99, 1.56) 1.00 <0.0001
CVD death a 204/16994 4.66 (2.31, 9.43) 3.53 (1.75, 7.11) 3.05 (1.50, 6.19) 2.97 (1.45, 6.07) 1.00 0.0007
All-cause death a b 1043/20308 2.14 (1.68, 2.73) 1.63 (1.29, 2.07) 1.44 (1.13, 1.84) 1.18 (0.92, 1.53) 1.00 <0.0001
SF 36 Mental summary component quintile
Q1: 0 – 48.0
(n = 4061)
Q2: 48.1 – 54.0
(n = 4063)
Q3: 54.1 – 57.0
(n = 4061)
Q4: 57.1 – 59.3
(n = 4065)
Q5: 59.4 - 75
(n = 4058)
Events/N HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) Ref p-value
CVD incidence a 1075/16994 0.96 (0.80, 1.17) 0.93 (0.77, 1.16) 0.82 (0.68, 0.99) 0.99 (0.82, 1.20) 1.00 0.29
CVD death a 204/16994 1.33 (0.90, 1.95) 0.63 (0.39, 1.01) 0.76 (0.48, 1.19) 0.87 (0.56, 1.35) 1.00 0.02
All-cause death a b 1043/20308 1.10 (0.91, 1.32) 0.93 (0.77, 1.13) 0.95 (0.79, 1.16) 0.96 (0.79, 1.17) 1.00 0.46
a Models were adjusted for age, ethnicity, education, marital status, body mass index, fruits and vegetables (servings/day), physical activity (MET/wk), smoking
history (pack-years), alcohol consumption status, systolic and diastolic blood pressure (mmHg), medication for hypertension or cholesterol, and diabetes, Chronic
obstructive pulmonary disease (asthma and emphysema), arthritis, cancer at baseline, mental component summary (when physical component summary was the
exposure), and physical component summary (when mental component summary was the exposure).
b Also adjusted for CVD at baseline in addition to the variables mentioned above.
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Most previous studies have similarly reported either a
null or weak association between the mental domain of
HRQOL and survival [8,26,27]. A possible explanation is
that SF-36 is better at assessing mental health well-being
and not designed to detect severe mental disorders, hence
the lack of an association.
Beyond the summary scales (PCS, MCS), this study
showed that physical functioning and general health
subscale were two most important of the eight subscales
of SF-36, in that they were significantly associated with
the outcomes. Although these findings are similar to
what have been reported in the literature [6,28], they
should be taken with caution, as the subscales are highly
correlated with one another, and hence their effects are
not independent.
The implications of this study’s findings are potentially
important to clinicians and researchers. First, PCS should
be tested as a screening tool in the healthy adult popula-
tion to identify those who are at-risk of CVD compared to
the existing practices (e.g. blood pressure, serum lipid).
Second, studies should explore whether an improvement
(or decline) in PCS score over time may also be associated
with a decreased (or increased) likelihood of CVD inci-
dence. There is already evidence to show that improve-
ments in PCS are associated with better survival, and that
lifestyle interventions can be effective in reducing the rate
of decline in PCS among older adults [14,22,29].
This study has several strengths, including a large sam-
ple, long follow-up, the use of a validated quality of life and
physical activity scale, objective height, weight, and blood
pressure measures, and detailed information on demo-
graphics, lifestyle factors, and health conditions, therebyenabling control for potential confounders. A further
strength is the high quality comprehensive ascertain-
ment of outcomes, including centrally adjudicated CVD
and other health outcomes.
Despite adjustment for chronic conditions at baseline,
there may be residual confounding in the analytical models
and the effect of unmeasured confounding factors cannot
be ruled out, both of which are potential limitations and
may partly explain the results. Further, participants’ health
conditions at baseline were self-reported.
Conclusion
Perceived physical health was a strong predictor of inci-
dent CVD (fatal and non-fatal), CVD-specific death, and
all-cause death in community dwelling postmenopausal
women. Women in the lowest quintile of perceived phys-
ical health had substantially higher risk for incident CVD
compared to women in the highest quintile. They also had
higher risk of CVD specific and all-cause death. Future
studies should test the value of PCS as a potential screen-
ing tool in older women to identify those who are at high
risk for CVD development.
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